We are live on ! Find out more
OC

Oppenheimer & Co Portfolio holdings

AUM $8.21B
1-Year Est. Return 28.81%
This Fund
S&P 500
This Quarter Est. Return
+3.54%
1 Year Est. Return
+28.81%
3 Year Est. Return
+92.54%
5 Year Est. Return
+114.67%
10 Year Est. Return
+429.8%
AUM
$3.44B
AUM Growth
+$5.13M
Cap. Flow
-$60.9M
Cap. Flow %
-1.77%
Top 10 Hldgs %
13.68%
Holding
1,403
New
134
Increased
468
Reduced
577
Closed
124

Top Sells

Rank Stock Value
1
BAC icon
Bank of America
BAC
+$7.91M
2
SBUX icon
Starbucks
SBUX
+$6.48M
3
CVS icon
CVS Health
CVS
+$6M
4
MDT icon
Medtronic
MDT
+$5.54M
5
WMT icon
Walmart Inc
WMT
+$5.12M

Sector Composition

Rank Sector Weight
1 Healthcare 12.56%
2 Financials 11.38%
3 Technology 10.34%
4 Industrials 9.82%
5 Consumer Discretionary 8.93%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BABA icon
251
Alibaba
BABA
$279B
$3.35M 0.1%
38,116
-6,762
-15% -$651K
VFC icon
252
VF Corp
VFC
$5.88B
$3.35M 0.1%
66,643
-52,118
-44% -$2.7M
IYZ icon
253
iShares US Telecommunications ETF
IYZ
$1.18B
$3.34M 0.1%
96,714
+87,288
+926% +$2.81M
FUN icon
254
Cedar Fair
FUN
$1.81B
$3.33M 0.1%
51,796
+29
+0.1% +$1.74K
SO icon
255
Southern Company
SO
$109B
$3.31M 0.1%
67,319
+6,157
+10% +$302K
YUMC icon
256
Yum China
YUMC
$15.9B
$3.31M 0.1%
+126,647
New +$3.45M
ITA icon
257
iShares US Aerospace & Defense ETF
ITA
$14.1B
$3.3M 0.1%
46,926
+1,780
+4% +$121K
VEA icon
258
Vanguard FTSE Developed Markets ETF
VEA
$230B
$3.25M 0.09%
88,980
+4,483
+5% +$164K
ABEV icon
259
Ambev
ABEV
$48.2B
$3.21M 0.09%
652,868
+64,612
+11% +$349K
GHDX
260
DELISTED
Genomic Health, Inc.
GHDX
$3.2M 0.09%
108,749
-30,000
-22% -$915K
FCX icon
261
Freeport-McMoran
FCX
$91.2B
$3.19M 0.09%
241,751
-5,311
-2% -$67.9K
APA icon
262
APA Corp
APA
$12.8B
$3.15M 0.09%
49,629
-1,746
-3% -$110K
MLM icon
263
Martin Marietta Materials
MLM
$32.4B
$3.13M 0.09%
14,148
+1,773
+14% +$364K
IVW icon
264
iShares S&P 500 Growth ETF
IVW
$72.7B
$3.12M 0.09%
102,504
+12,204
+14% +$369K
BIP icon
265
Brookfield Infrastructure Partners
BIP
$19.5B
$3.11M 0.09%
156,188
-12,689
-8% -$250K
MITT
266
TPG Mortgage Investment Trust
MITT
$225M
$3.1M 0.09%
60,407
-3,229
-5% -$160K
TTC icon
267
Toro Company
TTC
$8.72B
$3.1M 0.09%
55,394
+18,405
+50% +$939K
EMR icon
268
Emerson Electric
EMR
$83.3B
$3.1M 0.09%
55,505
+27
+0% +$1.45K
LYB icon
269
LyondellBasell Industries
LYB
$19.5B
$3.07M 0.09%
35,834
-2,950
-8% -$248K
VWO icon
270
Vanguard FTSE Emerging Markets ETF
VWO
$119B
$3M 0.09%
83,834
+3,136
+4% +$115K
AEP icon
271
American Electric Power
AEP
$69.5B
$2.99M 0.09%
47,552
+1,355
+3% +$83.6K
AXS icon
272
AXIS Capital
AXS
$7.67B
$2.98M 0.09%
45,590
-7,160
-14% -$431K
EQNR icon
273
Equinor
EQNR
$96.8B
$2.97M 0.09%
162,810
-755
-0.5% -$12.9K
TWX
274
DELISTED
Time Warner Inc
TWX
$2.96M 0.09%
30,632
+6,220
+25% +$554K
MS icon
275
Morgan Stanley
MS
$330B
$2.95M 0.09%
69,916
-28,283
-29% -$1.07M

Similar funds

Oppenheimer & Co's Q4 2016 Portfolio in Review

As of Q4 2016, Oppenheimer & Co held 1,403 positions worth $3.44B, up 0.15% from $3.43B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Oppenheimer & Co's Q4 2016 filing shows 134 new, 468 increased, 577 reduced and 124 closed positions. Its largest new stake was Yum China: 126,647 shares worth $3.31M. The largest sale was Bank of America, an estimated $7.91M.

By sector, the portfolio is most concentrated in Healthcare at 13% of assets, down from 14% a quarter earlier, followed by Financials and Technology.

  • Oppenheimer & Co's largest Q4 2016 buy was Yum China: 126,647 shares worth $3.31M.
  • Oppenheimer & Co added most to Lumen in Q4 2016, an estimated $7.38M increase.
  • Oppenheimer & Co's biggest Q4 2016 reduction was Bank of America, cutting an estimated $7.91M.
  • Oppenheimer & Co fully exited iShares MBS ETF in Q4 2016, selling an estimated $3.35M.
  • Oppenheimer & Co's ten largest holdings make up 14% of its $3.44B portfolio in Q4 2016.
  • Oppenheimer & Co opened 134 new positions and closed 124 in Q4 2016.
  • Oppenheimer & Co's portfolio value rose 0.15% quarter-over-quarter to $3.44B.

Based on Oppenheimer & Co's 13F filing for Q4 2016, filed 2 Feb 2017.